AMEX Stock Alert – IsoRay achieves Milestone, Shares Spike

July 9, 2011, 9:58 pm

Shares of IsoRay Inc. (AMEX: ISR), a Washington-based company engaged in the development, manufacturing and sale of isotope-based medical products and devices for treatment of cancer and other diseases, are climbing in today’s trading after the company achieved another milestone in the use of its proprietary Cesium-131 brachytherapy seeds in mesh.

IsoRay announced that Dr. Deepak Khuntia, who is one of U.S.’s leading thought leaders in brain and lung tumors, performed the first ever implant of Cesium-131 mesh brachytherapy in early stage lung cancer patient using the da Vinci® Surgical System. The surgery was performed at the El Camino Hospital in California.

Patients with stage 1 lung cancer have very limited treatment options. However, with Cesium-131 mesh brachytherapy, the odds shift in the favor of the patient as the mesh bracytherapy can dramatically reduce the recurrence rate for early-stage lung cancer patients, according to Dr. Khuntia. Employing the da Vinci robot to implant the Cesium-131 mesh brachytherapy further reduces the radiation exposure for physicians and is also safer for patients.

IsoRay CEO Dwight Babcock said that the combination of da Vinci robotics and the company’s Cesium-131 mesh brachytherapy represents another crucial leap forward in cancer treatment. Babcok also said that doctors now have an aggressive, effective treatment option for patients, which has a direct impact on patient survivability that comes with improved quality of life.

Shares soared toward 10% gains in todays mid-day trade at $1.22.

This newsletter has been helping traders make a killing on ISR. for a 25% discount offer.
See todays top stock picks and market analysis
Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
Want more? Check out the message board buzz for ISR
See what newsletters are recommending this stock pick
Get breaking news alerts on these stocks:

About BeaconEquity.com

BeaconEquity.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Stocks to Watch